News

There is currently no cure for cystic fibrosis (CF), a debilitating, progressive condition with over 10,830 people in the UK currently diagnosed with the disease.

Since April 2021, around 84,000 pregnant women have received at least one COVID-19 vaccination.

The chronic, inflammatory disease affects an estimated 24 in every 10,000 people.

The platform integrates primary human tissue samples into early target and drug discovery research.

With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.

Testing rules for COVID-19 are set to be eased for those who test positive on a lateral flow test but are asymptomatic.

The companies share the goal of furthering knowledge around GPCR biology in immune cells in order to better understand a range of immune system disorders.

The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.

Pressure on care and NHS staff mounts with the spread of the latest Omicron variant of COVID-19.

In order to help to reduce transmission of the Omicron variant, measures have been instated in hospitals, including a ban on ward visitations.

Pfizer’s Paxlovid has a success rate of nearly 90% as a prophylaxis treatment against severe COVID-19 when administered shortly after the patient has been infected with the virus.

Government vaccine advisers have said vulnerable primary school children should be offered a low-dose of a COVID-19 vaccine.

WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.

With authorisation, Pfizer’s oral antiviral candidate Paxlovid is an investigational SARS-CoV-2 protease inhibitor could be prescribed at the first sign of COVID-19 infection.

Calls for booster vaccinations in order to combat the rising cases brought about by winter and the recent Omicron variant have intensified, in the midst of record case rates.